https://stock.noler.com/us/stock/astex-pharmaceuticals-inc https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/clinical-trials https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/contribution-of-property https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/cost-method-investments-aggregate-carrying-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-investments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/deferred-tax-liabilities-tax-deferred-income https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/equity-method-investment-aggregate-cost https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/goodwill-acquired https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/goodwill-translation-adjustments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/income-taxes-receivable https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-other-operating-liabilities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/incremental-common-shares-attributable-to-contingently-issuable-shares https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/license-and-services-revenue https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/oci-securities-sale-reclassification-net-of-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/other-than-temporary-impairment-losses-investments-portion-recognized-in-earnings-net https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/patents-rejected https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/royalty-revenue https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-prem14a https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-s-4 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-pos-ex https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/transfer-to-investments https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/utb-income-tax-penalties-expense https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/utb-interest-on-income-taxes-expense https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/astex-pharmaceuticals-inc/warrants-and-rights-outstanding